-
Syros Pharmaceuticals (NASDAQ:SYRS) Receives Hold Rating from Brookline Capital Management
Source: Buzz FX / 13 Nov 2024 07:56:17 America/Chicago
Syros Pharmaceuticals (NASDAQ:SYRS) Receives Hold Rating from Brookline Capital Management Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Syros Pharmaceuticals ( NASDAQ:SYRS - Get Free Report ) 's stock had its "hol
Read more...